NCT05208814 A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects Status COMPLETED Phase PHASE1
NCT05203510 A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05185011 Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function Status COMPLETED Phase PHASE1
NCT05167825 A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT05147805 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT05135000 Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE2
NCT05124015 Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT05060315 Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin Status TERMINATED Phase N/A
NCT05039086 Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5 Status COMPLETED Phase N/A
NCT05036135 A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2/PHASE3
NCT04994860 Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil Status COMPLETED Phase PHASE1
NCT04991207 Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan Status COMPLETED Phase PHASE1
NCT04991194 Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058 Status TERMINATED Phase PHASE1
NCT04991181 Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 Status COMPLETED Phase PHASE1
NCT04972656 Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension Status RECRUITING Phase NA